Article Details
Retrieved on: 2024-06-08 21:25:26
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the S&P Dow Jones Indices’ rebalancing, including dropping biotech firm Illumina from the S&P 500 to the S&P MidCap 400, and adding companies like CrowdStrike and KKR to the S&P 500, reflecting industry shifts and market capitalizations.
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here